✦ LIBER ✦

A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma

✍ Scribed by H.M. Khaled; M.R. Hamza; O. Mansour; R. Gaafar; M.S. Zaghloul

Book ID: 117656820
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 78 KB
Volume: 36
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(00)00079-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Adjuvant Gemcitabine p

Phase II Trial of Adjuvant Gemcitabine plus Cisplatin-Based Chemotherapy in Patients with Locally Advanced Bladder Cancer

✍ James O. Jin; Jan Lehmann; Jerome Taxy; Dezheng Huo; Michael Stöckle; Nicholas J 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 126 KB

A Phase II study of gemcitabine and cisp

A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer

✍ Doval, D C; Sekhon, J S; Gupta, S K; Fuloria, J; Shukla, V K; Gupta, S; Awasthy, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

Cyclophosphamide, adriamycin and cisplat

Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II study

✍ Mulder, J.H.; Fossa, S.D.; de Pauw, M.; van Oosterom, A.T. 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 204 KB

Concurrent cisplatin/gemcitabine chemoth

Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: A phase II trial

✍ J. Umanzor; M. Aguiluz; C. Pineda; S. Andrade; M. Erazo; Claudio Flores; Sergio 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase II study of gemcitabine plus vinor

Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma

✍ Chuan-Cheng Wang; Jang-Yang Chang; Tsang-Wu Liu; Chin-Yu Lin; Yu-Chieh Yu; Ruey- 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Background. A phase II study was conducted to evaluate the safety and efficacy of a gemcitabine plus vinorelbine combination (GV) for patients with cisplatin-resistant nasopharyngeal carcinoma (NPC). Methods. Thirty-nine eligible patients received vinorelbine, 20 mg/m 2 , followed by gemcitabine, 1

A phase II study of gemcitabine and cisp

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas

✍ Lee, J K; Capanu, M; O'Reilly, E M; Ma, J; Chou, J F; Shia, J; Katz, S S; Gansuk 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 261 KB